Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

New Microplate Designed for High-Resolution Microscopy

By BiotechDaily International staff writers
Posted on 12 Mar 2013
Image: The new 96-well “ScreenStar” microplate for high-resolution microscopy (Photo courtesy of Greiner Bio-One).
Image: The new 96-well “ScreenStar” microplate for high-resolution microscopy (Photo courtesy of Greiner Bio-One).
A new, black 96-well microplate includes an ultra-low well base that enables high-magnification microscopy, inclusive of perimeter wells, even with a minimum working distance.

Greiner Bio-One (Frickenhausen, Germany) now expands its microplate portfolio with the introduction of “ScreenStar” at the 2013 Society for Laboratory Automation and Screening (SLAS) conference exhibition in Orlando (FL, USA). The ScreenStar design includes several new features. Manufactured entirely of cycloolefin, an innovative material with glass-like optical properties, it facilitates outstanding image quality of well contents. The microplate has a 190 μm ultraclear film bottom. The key advantage of ScreenStar over other plates for high-resolution microscopy is the extremely short distance between the well bottom and the microplate skirt (internal well to skirt bottom = 0.7 mm; external well to skirt bottom = 0.51 mm), rendering ease of high magnification microscopy at perimeter wells without complex microscopic adjustments. The circular wells allow microscopic work without disruptive shadow using the smallest possible meniscus lens. The perimeter ditch can be filled with water or medium to reduce edge effect due to evaporation, especially for long incubation periods. A proven cell culture-treatment quality ensures reliable, uniform growth.

The black, 96-well, 190 μm clear film bottom, cell culture treated, cycloolefin ScreenStar microplate comes sterile with lid, individually packed. Well bottoms are protected by a film that must be removed prior to use. The identical microscopy plate with a glass bottom will be introduced shortly.

Related Links:
Greiner Bio-One



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Difference in DP103 (red) levels in a healthy person (left image) and a breast cancer patient (right image) (Photo courtesy of the National University of Singapore).

BP103 Cited as Breast Cancer Biomarker and Potential Treatment Target

Cancer researchers in Singapore have identified the DP103 oncogene in human breast cancers as a biomarker for the molecular processes that drive reappearance and metastasis of tumors following chemotherapy.... Read more

Drug Discovery

view channel
Image: (Left) Neurons in brains from people with autism do not undergo normal pruning during childhood and adolescence. The images show representative neurons from unaffected brains (left) and brains from autistic patients (right); the spines on the neurons indicate the location of synapses (Photo courtesy of Guomei Tang, PhD and Mark S. Sonders, PhD, Columbia University Medical Center).

Autistic Youngsters Found to Have Too Many Brain Synapses

Autistic children and adolescents have been shown to have an excess of brain synapses, and this is due to a slowdown in the normal brain “trimming” process during development, according to new findings.... Read more

Therapeutics

view channel
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice. Liver cancer often results... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.